PD-1+ CD4 and CD8 T lymphocytes

1 paper1 finding

Human trial1

Interventions

1

Everolimus

downin humans1

1 study

Everolimus decreases PD-1+ CD4 and CD8 T lymphocytes in humans.
Human trial
mTOR inhibition improves immune function in the elderly
Science translational medicine24 Dec 2014

More on Everolimus

Latest

Science Translational Medicine24 Dec

mTOR inhibition improves immune function in the elderly

Randomised trial in peoplemTOR inhibitors